DRI Healthcare Trust (DHT.UN) Stock Price, News & Analysis

Company Overview

DRI Healthcare Trust is managed by DRI Capital Inc. DRI a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable patent-protected cash flow streams derived from the sales of those important drugs while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products and proudly work with multiple repeat deal partners.DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21 2020 as amended.DRI Healthcare Trusts units are listed and trade on the Toronto Stock Exchange under DHT.UN in Canadian dollars and under DHT.U in U.S. dollars.

Key Stats

• Today's Range: C$17.18 to C$17.69
• 50-Day Range: C$17.11 to C$19.65
• 52-Week Range: C$14.10 to C$19.75
• Volume: 50,612 shs
• Average Volume: 56,017 shs
• Market Capitalization: C$955.81 million
• P/E Ratio: N/A
• Dividend Yield: 2.42%
• Price Target: C$25.20
• Consensus Rating: Buy

DRI Healthcare Trust Stock Analysis - MarketRank™

DRI Healthcare Trust scored higher than 54% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.2 / 5
• Analyst Rating: Buy

Consensus Rating

DRI Healthcare Trust has received a consensus rating of Buy. The company's average rating score is 3.20, and is based on 1 strong buy rating, 4 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

DRI Healthcare Trust has a consensus price target of C$25.20, representing about 45.2% upside from its current price of C$17.35.

Amount of Analyst Coverage

DRI Healthcare Trust has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of DRI Healthcare Trust is -21.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of DRI Healthcare Trust is -21.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

DRI Healthcare Trust has a P/B Ratio of 1.86. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for DHT.UN.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

DRI Healthcare Trust pays a meaningful dividend of 3.45%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

DRI Healthcare Trust does not have a long track record of dividend growth.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 1.49

News Sentiment

DRI Healthcare Trust has a news sentiment score of 1.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.79 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for DRI Healthcare Trust this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, DRI Healthcare Trust insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.14% of the stock of DRI Healthcare Trust is held by insiders.

Percentage Held by Institutions

0.78% of the stock of DRI Healthcare Trust is held by institutions.

Company Calendar

• Ex-Dividend for 7/20 Dividend: 6/30/2026
• Record date for 7/20 Dividend: 7/20/2026
• Dividend Payable: 7/20/2026
• Today: 9/08/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: TSE:DHT.UN
• CIK: N/A
• Web: www.dricapital.com
• Phone: 416-863-1865
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for DRI Healthcare Trust: C$25.20
• High Price Target: C$30.00
• Low Price Target: C$23.00
• Potential Upside/Downside: +44.9%
• Consensus Rating: Buy
• Rating Score (0-4): 3.20
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): C($0.80)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 27.37
• P/E Growth: N/A
• Net Income: C$9.73 million
• Net Margins: 5.02%
• Pretax Margin: N/A
• Return on Equity: 2.06%
• Return on Assets: 4.22%

Debt

• Debt-to-Equity Ratio: 63.20
• Current Ratio: 1.36
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: C$172.34 million
• Price / Sales: 5.55
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: C$9.32 per share
• Price / Book: 1.87

Miscellaneous

• Outstanding Shares: 54,963,000
• Free Float: N/A
• Market Cap: C$955.81 million
• Optionable: N/A
• Beta: 0.37